Uflex says COVID-19 may propel development of sterile, anti-microbial packaging solutions

Uflex revenues could grow 12-15% in FY21, as new projects are commissioned during the year, Rajesh Bhatia, Group President (Finance Accounts) CFO UFlex told Moneycontrol

from Moneycontrol Business News https://www.moneycontrol.com/news/business/uflex-says covid-19-may-propel-developmentsterile-anti-microbial-packaging-solutions_13937041.html